Synthesis and Biological Evaluation of Novel Carbazole Hybrids as Promising Antimicrobial Agents. 2020

Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal (Westville), Durban, 4000, South Africa.

Two series of carbazole analogs of 8-methoxy-N-substituted-9H-carbazole-3-carboxamides (series 1) and carbazolyl substituted rhodanines (series 2) were synthesized through facile synthetic routes. All the final compounds from these two series were evaluated for their preliminary in vitro antifungal and antibacterial activity against four fungal (Candida albicans, Cryptococcus neoformans, Cryptococcus tropicalis and Aspergillus niger) and four bacterial (Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa) strains, respectively. Among the tested compounds, three compounds of series 1 displayed promising antifungal and antibacterial activity, especially against C. neoformans and S. aureus. In addition, one compound of series 1 displayed notable antimicrobial activity (MIC: 6.25 μg/mL) against clinical isolates of C. albicans and C. neoformans (MIC: 12.5 μg/mL). From the second series, four compounds exhibited significant antifungal and antibacterial activity, especially against C. neoformans and S. aureus. The most active compound of series 2 displayed a prominent antimicrobial activity against C. neoformans (MIC: 3.125 μg/mL) and S. aureus (MIC: 1.56 μg/mL), respectively.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D003454 Cryptococcus A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium. Torula
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001234 Aspergillus niger An imperfect fungus causing smut or black mold of several fruits and vegetables such as grapes, apricots, onions, and peanuts, and is a common contaminant of food. Aspergillus lacticoffeatus

Related Publications

Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
September 2017, Bioorganic & medicinal chemistry letters,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
March 2024, Archiv der Pharmazie,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
May 2023, RSC medicinal chemistry,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
December 2016, ACS medicinal chemistry letters,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
August 2014, Bioorganic & medicinal chemistry letters,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
July 2009, European journal of medicinal chemistry,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
March 2014, European journal of medicinal chemistry,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
December 2022, Chemico-biological interactions,
Mahamadhanif S Shaikh, and Balakumar Chandrasekaran, and Mahesh B Palkar, and Ashish M Kanhed, and Afsana Kajee, and Koleka P Mlisana, and Parvesh Singh, and Meenu Ghai, and Mavela Cleopus Mahlalela, and Rajshekhar Karpoormath
December 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!